ENHANCING PATIENT QUALITY OF CARE
FDA Recognized Drug
Treatment for COVID-19
Founded in 2017 by Kamalesh Rao, Lifescient is a San Francisco Bay Area based pharmaceutical company specializing in drug delivery systems to improve the quality of patient care worldwide. These treatments have applications in humans as well as in veterinary medicine. Currently we are focusing on two specific areas: developing a treatment for COVID-19 and improving prescription compliance to treat and manage chronic diseases.
HARNESSING RESOURCES TO TREAT COVID-19
In response to the COVID-19 global pandemic, Lifescient is repurposing an existing FDA approved drug to develop a treatment for COVID-19
One of the greatest challenges facing the medical community worldwide is that prescription compliance is often not met in cases of medications used for chronic conditions. This problem prevents people from receiving the benefits expected from their medication and costs the consumer billions of dollars every year in wasted medical expenses. In the case of veterinary medicine, daily dosing of pets can be stressful, difficult and oftentimes requiring multiple clinic visits. To address this problem, we are developing subcutaneous implants loaded with previously approved drugs that will deliver medications on a long-term basis to treat chronic conditions. These implants will ensure prescription compliance, minimize side effects, prevent drug diversion, and vastly improve the overall quality of care.